Proud to announce with @ScottPLand and the @LiverImmunoreg1 team our #Naturecomm paper on a new #cellincell structure with T CD8+E-cadh+ cells invading BECs! A breakthrough in #PBC pathogenesis. Check out the details and Scott’s twittorial: https://t.co/YmySQ05NbK #livertwitter
🚨NEW PAPER!! It gives me great pleasure to say that our latest publication is now out in @NatureComms! 🥳🥳 Here we report a new form of #cellincell structure in which #CD8 T cells can express E-cadherin and invade biliary epithelial cells!
Link here! https://t.co/VJzBAAS0Rl.
We’re officially underway in Las Vegas for the 2026 #AASLDETC! Over the next three days, attendees from New Orleans to Mexico City are diving into steatosis, cholestasis, MASLD, MetALD, PBC, PSC, fibrosis assessment, and emerging translational science shaping patient care.
What questions do you have about these areas of liver disease research? Comment below!
Looking forward to talking about T cell–cholangiocyte interactions in PBC at BioGipuzkoa. Thanks @PMRodrigues19 and @JesusMBanales for the kind invitation
📅 June 13 – 13:30
📍 Salón de actos
#Immunology#PBC#Hepatology
@AASLDtweets@EASLnews Masterclass in Savannah, GA - 🌟speakers, great 🧪science discussions, and a scenic city⛲️!
🔑:
- Establish your dream team
- Make a 5y plan and build a culture
- 💰=reality!
- Be efficient to ⚖️work-life
#livertwitter@AleksanderKrag@AASLDPresident
In today’s #readoftheweek📚, the authors’ findings highlight the role of liver biopsy in elucidating the underlying pathology and aiding in the diagnosis of patients with persistent and unexplained GGT elevation.
Read here this @JHEP_Reports article: https://t.co/cWjRP5o1dt
🙏 @nicolapugliese_, @FRPonziani, @lucavalenti75, @AghemoAlessio et al.
The Birmingham liver unit become a happier place today with the news of appointments of Professors Ferguson & Armstrong. So well deserved. In daily awe of your amazing clinical/research skills along with your patient focussed care. @jfergus75@Drfattyliver@uhbtrust
Can we predict failure to #OCA in #PBC patients?
The simple answer is YES❗️
OCA-response score: a novel tool to drive treatment allocation for 2nd-line therapies
@AASLDtweets@EASLedu#livertwitter
Read full paper on the two largest OCA cohorts
https://t.co/ikhQUrXU6w
Congratulations to Jesse Kirkpatrick, long time colleague tackling PSC and its dreaded complications through bold research! @PSCPartners @PSCPartnersCa@AASLDtweets
Proud to announce with @ScottPLand and the @LiverImmunoreg1 team our #Naturecomm paper on a new #cellincell structure with T CD8+E-cadh+ cells invading BECs! A breakthrough in #PBC pathogenesis. Check out the details and Scott’s twittorial: https://t.co/YmySQ05NbK #livertwitter
🚨NEW PAPER!! It gives me great pleasure to say that our latest publication is now out in @NatureComms! 🥳🥳 Here we report a new form of #cellincell structure in which #CD8 T cells can express E-cadherin and invade biliary epithelial cells!
Link here! https://t.co/VJzBAAS0Rl.
The journey toward this publication marked most of my phd. I had the pleasure and honour to be mentored and tutored by Prof Oo and @ScottPLand himself who is just the perfect guide and the most lovely person to have around especially in a such difficult task. HUGE THANKS to him
@ScottPLand This is great part of my #JuanRodesEASL fellowship and I must thank @EASLedu for the support. Nothing would have been possible without the biggest drive of this investigation which is to provide new insight and therapeutic opportunities for our patients @PBCFoundation @PBCRobert